K2 Veterans Total Coverage Act of 2024
Latest Action
Referred to the Subcommittee on Disability Assistance and Memorial Affairs.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The K2 Veterans Total Coverage Act of 2024 is a bill introduced in the 118th Congress aimed at addressing issues related to veterans exposed to K2, a synthetic cannabinoid. The bill was referred to the Subcommittee on Disability Assistance and Memorial Affairs but ultimately failed or expired without further legislative action. The bill falls under the policy area of Armed Forces and National Security. No official summary or full text is available, limiting detailed analysis of its provisions.
This bill sought to provide coverage or benefits related to K2 exposure for veterans but did not advance beyond subcommittee referral and expired without enactment.
- The bill is titled 'K2 Veterans Total Coverage Act of 2024' and was introduced in the House of Representatives.
- It was referred to the Subcommittee on Disability Assistance and Memorial Affairs on September 11, 2024.
- The bill status is marked as Failed / Expired, indicating it did not pass into law during the 118th Congress.
['Veterans exposed to K2 synthetic cannabinoids', 'Veterans Affairs agencies responsible for disability and memorial affairs']
['Lack of available full bill text and official summary limits understanding of specific provisions and implementation requirements.', 'Failure to advance beyond subcommittee may reflect challenges in legislative support or prioritization.', 'Potential costs or administrative burdens related to coverage expansion for veterans exposed to K2 are unknown.']
The bill was introduced during the 118th Congress and referred to a relevant subcommittee focused on veterans' disability and memorial affairs. Its failure to progress suggests it did not gain sufficient legislative momentum or priority within the Armed Forces and National Security policy area during this session.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['If enacted, the bill could have led to expanded healthcare or disability benefits for veterans exposed to K2, potentially increasing demand on Veterans Affairs resources.', 'Failure to pass may delay or prevent formal recognition and coverage of health issues related to K2 exposure among veterans.', 'Legislative attention to K2-related veteran issues may influence future policy proposals or advocacy efforts.']
The absence of an official summary and full bill text limits transparency and public understanding of the bill's scope and provisions. The bill's failure to progress beyond subcommittee referral highlights the importance of tracking legislative movement to assess policy impact potential. Oversight entities should monitor similar future proposals to ensure adequate consideration of veterans' health concerns related to synthetic cannabinoids.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.